On the public citation graph
Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs
0 signed · 111 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4530852openalex-extracted
New Synthesis of Β-Aryl-Gaba Drugs
inferred← citeshttps://doi.org/10.1002/(sici)1097-0290(200024)71:1<9::aid-bit3>3.0.co;2-#openalex-snapshot
Streamlined synthesis of substituted 2‐Aminothiazoles using tandem precipitative and polymer‐assisted reactions
inferred← citeshttps://doi.org/10.1002/9780470399613.ch2openalex-snapshot
Drugs Based on a Substituted Benzene Ring
inferred← citeshttps://doi.org/10.1002/chin.199443106openalex-snapshot
ChemInform Abstract: Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3‐(Cyclopentyloxy)‐4‐ methoxybenzamides and Analogues.
inferred← citeshttps://doi.org/10.1002/chir.20665openalex-snapshot
Preparation of enantiopure (R)‐hydroxy metabolite of denbufylline using immobilized Lactobacillus kefiri DSM 20587 as a catalyst
inferred← citeshttps://doi.org/10.1002/cmdc.202000122openalex-snapshot
Discovery of New Antiproliferative Imidazopyrazole Acylhydrazones Able To Interact with Microtubule Systems
inferred← citeshttps://doi.org/10.1002/jhet.5570340301openalex-snapshot
Nitration in the imidazo[1,2‐a]pyrazine series. Experimental and computational results
inferred← citeshttps://doi.org/10.1006/bbrc.2001.5786openalex-snapshot
Anti-TNF-α Properties of New 9-Benzyladenine Derivatives with Selective Phosphodiesterase-4- Inhibiting Properties
inferred← citeshttps://doi.org/10.1007/978-3-0348-8751-9_3openalex-snapshot
Phosphodiesterases in Asthma
inferred← citeshttps://doi.org/10.1007/bf02976547openalex-snapshot
Synthesis and biological studies of catechol ether type derivatives as potential phosphodiesterase (PDE) IV inhibitors
inferred← citeshttps://doi.org/10.1007/s00894-020-04485-3openalex-snapshot
Spectral analysis and detailed quantum mechanical investigation of some acetanilide analogues and their self-assemblies with graphene and fullerene
inferred← citeshttps://doi.org/10.1016/0960-894x(95)00333-oopenalex-snapshot
Discovery of micromolar PDE IV inhibitors that exhibit much reduced affinity for the [3H]rolipram binding site: 3-norbornyloxy-4-methoxyphenylmethylene oxindoles
inferred← citeshttps://doi.org/10.1016/0960-894x(95)00336-ropenalex-snapshot
Phosphodiesterase type IV (PDE IV) inhibition. Synthesis and evaluation of a series of 1,3,4-trisubstituted pyrrolidines
inferred← citeshttps://doi.org/10.1016/b0-08-045044-x/00232-7openalex-snapshot
Asthma and Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1016/b978-012210720-7/50009-5openalex-snapshot
Interaction of PDE4 Inhibitors with Enzymes and Cell Functions
inferred← citeshttps://doi.org/10.1016/b978-012210720-7/50014-9openalex-snapshot
Characterization of Different States of PDE4 by Rolipram and RP 73401
inferred← citeshttps://doi.org/10.1016/b978-012210720-7/50015-0openalex-snapshot
Molecular Aspects of Inhibitor Interaction with PDE4
inferred← citeshttps://doi.org/10.1016/j.alcohol.2015.03.007openalex-snapshot
Phosphodiesterase regulation of alcohol drinking in rodents
inferred← citeshttps://doi.org/10.1016/j.bmc.2005.09.023openalex-snapshot
Enaminones 9. Further studies on the anticonvulsant activity and potential type IV phosphodiesterase inhibitory activity of substituted vinylic benzamides
inferred← citeshttps://doi.org/10.1016/j.bmc.2006.08.026openalex-snapshot
Synthesis of carbon-11 labeled fluorinated 2-arylbenzothiazoles as novel potential PET cancer imaging agents
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.10.033openalex-snapshot
Catecholic amides as potential selective phosphodiesterase 4D inhibitors: Design, synthesis, pharmacological evaluation and structure–activity relationships
inferred← citeshttps://doi.org/10.1016/j.bmc.2019.07.015openalex-snapshot
Microwave-Assisted Organic Synthesis, structure–activity relationship, kinetics and molecular docking studies of non-cytotoxic benzamide derivatives as selective butyrylcholinesterase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2019.07.046openalex-snapshot
Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.03.023openalex-snapshot
Water-soluble PDE4 inhibitors for the treatment of dry eye
inferred← citeshttps://doi.org/10.1016/j.bpj.2020.08.037openalex-snapshot
Isoform-Selective Enzyme Inhibitors by Exploring Pocket Size According to the Lock-and-Key Principle
inferred← citeshttps://doi.org/10.1016/j.cdc.2019.100218openalex-snapshot
Crystal structure and theoretical studies of 2-bromo-N-(2,4-difluorobenzyl)benzamide; intermediate for the synthesis of phenanthridinone
inferred← citeshttps://doi.org/10.1016/j.ejmech.2003.09.001openalex-snapshot
3D-QSAR studies of indole derivatives as phosphodiesterase IV inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.08.018openalex-snapshot
New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.08.052openalex-snapshot
Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113638openalex-snapshot
Design, synthesis, biological evaluation and structural characterization of novel GEBR library PDE4D inhibitors
inferred← citeshttps://doi.org/10.1016/j.farmac.2003.08.005openalex-snapshot
Synthesis and biological evaluation of neutrophilic inflammation inhibitors
inferred← citeshttps://doi.org/10.1016/j.jid.2024.10.597openalex-snapshot
Chemical, Biochemical, and Structural Similarities and Differences of Dermatological cAMP Phosphodiesterase-IV Inhibitors
inferred← citeshttps://doi.org/10.1016/j.pupt.2005.09.002openalex-snapshot
Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors
inferred← citeshttps://doi.org/10.1016/j.tet.2023.133648openalex-snapshot
New synthesis of β-aryl-GABA drugs
inferred← citeshttps://doi.org/10.1016/j.tet.2025.135006openalex-snapshot
First total synthesis of tamaractam through cascade radical 1,4-aryl migration
inferred← citeshttps://doi.org/10.1016/j.tetasy.2013.01.009openalex-snapshot
A simple enantioselective route toward (R)- and (S)-Rolipram via anhydride desymmetrization
inferred← citeshttps://doi.org/10.1016/j.theochem.2007.06.010openalex-snapshot
Comparative molecular field analysis (CoMFA) for phosphodiesterase (PDE) IV inhibitors
inferred← citeshttps://doi.org/10.1016/s0014-5793(02)03396-3openalex-snapshot
Crystal structure of phosphodiesterase 4D and inhibitor complex1
inferred← citeshttps://doi.org/10.1016/s0022-3565(24)29538-0openalex-snapshot
In Vivo Efficacy in Airway Disease Models of Roflumilast, a Novel Orally Active PDE4 Inhibitor
inferred← citeshttps://doi.org/10.1016/s0022-3565(24)35356-xopenalex-snapshot
Pregnancy Induces a Modulation of the cAMP Phosphodiesterase 4-Conformers Ratio in Human Myometrium: Consequences for the Utero-Relaxant Effect of PDE4-Selective Inhibitors
inferred← citeshttps://doi.org/10.1016/s0065-7743(08)60447-9openalex-snapshot
Chapter 8. Chronic Pulmonary Inflammation and Other Therapeutic Applications of PDE IV Inhibitors
inferred← citeshttps://doi.org/10.1016/s0076-6879(06)14027-6openalex-snapshot
Protein Translocation Assays: Key Tools for Accessing New Biological Information with High‐Throughput Microscopy
inferred← citeshttps://doi.org/10.1016/s0079-6468(08)70302-3openalex-snapshot
1 Phosphodiesterase Type IV Inhibitors
inferred← citeshttps://doi.org/10.1016/s0079-6603(01)69049-4openalex-snapshot
PDE4 cAMP-specific phosphodiesterases
inferred← citeshttps://doi.org/10.1016/s0223-5234(97)87535-6openalex-snapshot
Synthesis and pharmacological evaluation of some amino-acid-containing cyproheptadine derivatives as dual antagonists of histamine H1- and leukotriene D4-receptors
inferred← citeshttps://doi.org/10.1016/s0960-894x(00)00426-1openalex-snapshot
7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma
inferred← citeshttps://doi.org/10.1016/s0960-894x(00)00449-2openalex-snapshot
The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I
inferred← citeshttps://doi.org/10.1016/s0960-894x(00)00587-4openalex-snapshot
Phthalazine PDE4 inhibitors. Part 2: The synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives
inferred← citeshttps://doi.org/10.1016/s0960-894x(01)00668-0openalex-snapshot
Phthalazine PDE4 inhibitors. Part 3: The synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor
inferred← citeshttps://doi.org/10.1016/s0960-894x(03)00405-0openalex-snapshot
Improvement of therapeutic index of phosphodiesterase type IV inhibitors as anti-Asthmatics
inferred← citeshttps://doi.org/10.1016/s0960-894x(03)00493-1openalex-snapshot
Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors
inferred← citeshttps://doi.org/10.1016/s0960-894x(98)00324-2openalex-snapshot
The synthesis and biological evaluation of a novel series of indole PDE4 inhibitors I
inferred← citeshttps://doi.org/10.1016/s0960-894x(98)00497-1openalex-snapshot
2-Substituted-4-methoxybenzimidazole-based PDE4 inhibitors
inferred← citeshttps://doi.org/10.1016/s0960-894x(98)00572-1openalex-snapshot
Orally active indole N-oxide PDE4 inhibitors
inferred← citeshttps://doi.org/10.1016/s0968-0896(98)00266-1openalex-snapshot
Phosphodiesterase 4 inhibitors as airways smooth muscle relaxant agents: synthesis and biological activities of triazine derivatives
inferred← citeshttps://doi.org/10.1016/s0968-0896(99)00038-3openalex-snapshot
Benzofuran based PDE4 inhibitors
inferred← citeshttps://doi.org/10.1016/s1054-3589(08)60128-3openalex-snapshot
The Multienzyme PDE4 Cyclic Adenosine Monophosphate–Specific Phosphodiesterase Family: Intracellular Targeting, Regulation, and Selective Inhibition by Compounds Exerting Anti-inflammatory and Antidepressant Actions
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b01804openalex-snapshot
Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain
inferred← citeshttps://doi.org/10.1021/cr4002879openalex-snapshot
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
inferred← citeshttps://doi.org/10.1021/ja208652nopenalex-snapshot
Silacarboxylic Acids as Efficient Carbon Monoxide Releasing Molecules: Synthesis and Application in Palladium-Catalyzed Carbonylation Reactions
inferred← citeshttps://doi.org/10.1021/jm201148sopenalex-snapshot
Pharmacological Validation of Trypanosoma brucei Phosphodiesterases B1 and B2 as Druggable Targets for African Sleeping Sickness
inferred← citeshttps://doi.org/10.1021/jm301059bopenalex-snapshot
Catechol Pyrazolinones as Trypanocidals: Fragment-Based Design, Synthesis, and Pharmacological Evaluation of Nanomolar Inhibitors of Trypanosomal Phosphodiesterase B1
inferred← citeshttps://doi.org/10.1021/jm500378aopenalex-snapshot
Discovery and Early Clinical Development of 2-{6-[2-(3,5-Dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}- N -propylacetamide (LEO 29102), a Soft-Drug Inhibitor of Phosphodiesterase 4 for Topical Treatment of Atopic Dermatitis
inferred← citeshttps://doi.org/10.1021/jm500855wopenalex-snapshot
Synthesis, Biological Evaluation, and Molecular Modeling of New 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-Dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) Related Phosphodiesterase 4D (PDE4D) Inhibitors
inferred← citeshttps://doi.org/10.1021/jm701635jopenalex-snapshot
Design, Synthesis, and Structure−Activity Relationship, Molecular Modeling, and NMR Studies of a Series of Phenyl Alkyl Ketones as Highly Potent and Selective Phosphodiesterase-4 Inhibitors
inferred← citeshttps://doi.org/10.1021/jm800582jopenalex-snapshot
Recent Advances on Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1021/jm900977copenalex-snapshot
New Selective Phosphodiesterase 4D Inhibitors Differently Acting on Long, Short, and Supershort Isoforms
inferred← citeshttps://doi.org/10.1021/op800058nopenalex-snapshot
Solving a Scale-Up Problem in the O -Alkylation of Isovanillin Under Phase-Transfer Catalysis Conditions
inferred← citeshttps://doi.org/10.1021/op9700385openalex-snapshot
Process Development of the PDE IV Inhibitor 3-(Cyclopentyloxy)- N -(3,5-dichloropyrid-4-yl)-4-methoxybenzamide
inferred← citeshttps://doi.org/10.1023/a:1008091001082openalex-snapshot
QSAR using 2D descriptors and TRIPOS' SIMCA
inferred← citeshttps://doi.org/10.1038/sj.bjp.0701200openalex-snapshot
Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin‐2 release from murine splenocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer
inferred← citeshttps://doi.org/10.1038/sj.bjp.0703725openalex-snapshot
The effect of selective and non‐selective phosphodiesterase inhibitors on allergen‐ and leukotriene C4‐induced contractions in passively sensitized human airways
inferred← citeshttps://doi.org/10.1039/c0md00215aopenalex-snapshot
Novel indolizine compounds as potent inhibitors of phosphodiesterase IV (PDE4): structure–activity relationship
inferred← citeshttps://doi.org/10.1039/c4md00277fopenalex-snapshot
Imidazole derivatives show anticancer potential by inducing apoptosis and cellular senescence
inferred← citeshttps://doi.org/10.1042/bj3210165openalex-snapshot
Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant
inferred← citeshttps://doi.org/10.1042/bj3210177openalex-snapshot
Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines
inferred← citeshttps://doi.org/10.1046/j.1365-2249.2002.01856.xopenalex-snapshot
Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors
inferred← citeshttps://doi.org/10.1089/adt.2006.4.679openalex-snapshot
A Simple Cell-Based HTS Assay System to Screen for Inhibitors of p53-Hdm2 Protein–Protein Interactions
inferred← citeshttps://doi.org/10.1111/j.1476-5381.1994.tb17156.xopenalex-snapshot
Anti‐inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor
inferred← citeshttps://doi.org/10.1111/j.1476-5381.1995.tb16317.xopenalex-snapshot
Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP‐specific phosphodiesterase: comparison with rolipram
inferred← citeshttps://doi.org/10.1111/j.1476-5381.1996.tb15450.xopenalex-snapshot
Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer
inferred← citeshttps://doi.org/10.1111/j.1476-5381.1996.tb15628.xopenalex-snapshot
Effects of RP 73401, a novel, potent and selective phosphodiesterase type 4 inhibitor, on contractility of human, isolated bronchial muscle
inferred← citeshttps://doi.org/10.1124/jpet.102.047407openalex-snapshot
Inhibitor Binding to Type 4 Phosphodiesterase (PDE4) Assessed Using [3H]Piclamilast and [3H]Rolipram
inferred← citeshttps://doi.org/10.1124/jpet.102.47407openalex-snapshot
Inhibitor Binding to Type 4 Phosphodiesterase (PDE4) Assessed Using [3H]Piclamilast and [3H]Rolipram
inferred← citeshttps://doi.org/10.1124/jpet.103.053942openalex-snapshot
In Vivo Efficacy in Airway Disease Models of N-(3,5-Dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic Acid Amide (AWD 12-281), a Selective Phosphodiesterase 4 Inhibitor for Inhaled Administration
inferred← citeshttps://doi.org/10.1124/mol.51.6.999openalex-snapshot
Role of Conserved Histidines in Catalytic Activity and Inhibitor Binding of Human Recombinant Phosphodiesterase 4A
inferred← citeshttps://doi.org/10.1124/mol.61.1.20openalex-snapshot
Molecular Docking of Competitive Phosphodiesterase Inhibitors
inferred← citeshttps://doi.org/10.1177/019262339902700401openalex-snapshot
Toxicologic and Carcinogenic Effects of the Type IV Phosphodiesterase Inhibitor RP 73401 on the Nasal Olfactory Tissue in Rats
inferred← citeshttps://doi.org/10.1201/9781420020847-33openalex-snapshot
Medicinal Chemistry of PDE4 Inhibitors
inferred← citeshttps://doi.org/10.1201/9781420020847.ch33openalex-snapshot
Medicinal Chemistry of PDE4 Inhibitors
inferred← citeshttps://doi.org/10.1201/b14830-10openalex-snapshot
Therapeutic Potential of Phosphodiesterase Type 4 Inhibitors in the Treatment of Asthma
inferred← citeshttps://doi.org/10.1210/en.2004-0562openalex-snapshot
Pharmacological Inhibition of Phosphodiesterase 4 Triggers Ovulation in Follicle-Stimulating Hormone-Primed Rats
inferred← citeshttps://doi.org/10.1248/cpb.49.1009openalex-snapshot
Synthesis and Structure-Activity Relationship of N-Arylrolipram Derivatives as Inhibitors of PDE4 Isozymes.
inferred← citeshttps://doi.org/10.1248/cpb.50.1163openalex-snapshot
Synthesis and Cyclic AMP Phosphodiesterase 4 Isoenzyme Inhibitory Activity of Heterocycle Condensed Purines.
inferred← citeshttps://doi.org/10.1517/13543776.6.4.411openalex-snapshot
Novel phophodiesterase inhibitors
inferred← citeshttps://doi.org/10.1517/13543776.7.9.989openalex-snapshot
Phosphodiesterase 4 inhibitors for the treatment of asthma
inferred← citeshttps://doi.org/10.1517/13543784.16.1.109openalex-snapshot
Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast
inferred← citeshttps://doi.org/10.2174/1386207322666190306142810openalex-snapshot
Comparison of the Full-Length and 152~528 Truncate of Human Cyclic Nucleotide Phosphodiesterase 4B2 for the Characterization of Inhibitors
inferred← citeshttps://doi.org/10.3184/174751914x14061300074410openalex-snapshot
Synthesis of An Impurity in Crude Roflumilast
inferred← citeshttps://doi.org/10.3184/174751915x14400926401559openalex-snapshot
A Facile Method for the Synthesis of Betrixaban
inferred← citeshttps://doi.org/10.3389/fnins.2014.00129openalex-snapshot
Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice
inferred← citeshttps://doi.org/10.3389/fonc.2017.00042openalex-snapshot
Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome Patient
inferred← citeshttps://doi.org/10.3390/antiox15010031openalex-snapshot
Design and Synthesis of New Coumarin Hybrids Active Against Drug-Sensitive and Drug-Resistant Neuroblastoma Cells
inferred← citeshttps://doi.org/10.3390/catal9100820openalex-snapshot
Synthesis of Pyrazolo-Fused 4-Azafluorenones in an Ionic Liquid. Mechanistic Insights by Joint Studies Using DFT Analysis and Mass Spectrometry
inferred← citeshttps://doi.org/10.3390/ijms24076817openalex-snapshot
To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?
inferred← citeshttps://doi.org/10.3390/ijms25094607openalex-snapshot
Structure–Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents
inferred← citeshttps://doi.org/10.3390/molecules25040899openalex-snapshot
New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets
inferred← citeshttps://doi.org/10.3892/mmr.2019.9802openalex-snapshot
Anti‑inflammatory effect of ciclamilast in an allergic model involving the expression of PDE4B
inferred← citeshttps://doi.org/10.5935/1984-6835.20150034openalex-snapshot
Structural Optimization of 6-aryl Pyridazin3-ones as Novel Potent PDE4 Inhibitors
inferred← citeshttps://doi.org/10.71193/jmct.20250009openalex-snapshot
Phosphodiesterase-4 Inhibitors in COPD Therapy: A Review of Mechanisms, Limitations, and Emerging Opportunities
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.